Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Flp-in TREx 293 |
Human embryonic kidney cell line (Derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | CRISPR | Metafectene PRO | publication | B. K. Shrestha et al., J. Biol. Chem., 2019,doi/10.1074/jbc.RA119.010068 | Link | ||
Flp-in TREx 293 |
Human embryonic kidney cell line (derivative of HEK293) | Human | urinary system | cell line | adherent | plasmid | CRISPR | Metafectene PRO | publication | B.K. Shrestha et al., J Biol Chem., 2020, 295(5): 1240–1260, doi: 10.1074/jbc.RA119.010068 | Link | ||
Flp-In TREx HeLa |
Human cervix adenocarcinoma cell line (derivative of HeLa) | Human | genital tract | cell line | adherent | plasmid | CRISPR | Metafectene PRO | publication | T. M. Nthiga et al., The EMBO J., 39: e103649, DOI 10.15252/embj.2019103649 | Link | ||
Flp-In TREx HeLa |
Human cervix adenocarcinoma cell line (derivative of HeLa) | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | N.E. Taboko, Masters Thesis, 2020, UiT Norges arktiske universitet | Link | ||
Flp-In TREx HeLa |
Human cervix adenocarcinoma cell line (derivative of HeLa) | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | T. M. Nthiga et al., The EMBO J., 39: e103649, DOI 10.15252/embj.2019103649 | Link | ||
FTC-133 |
Human follicular thyroid carcinoma/lymph node metastasis cell line | ECACC 94060901 | Human | other | cell line | adherent | plasmid | stable transfection | Metafectene | publication | J. Pyka et al., Cancer Res., Feb 2005; 65: 1343 - 1351 | Link | |
FTC-133 |
Human follicular thyroid carcinoma/lymph node metastasis cell line | ECACC 94060901 | Human | other | cell line | adherent | plasmid | Metafectene | publication | T. R. H. Büch et al., J. Biol. Chem., Jul 2008; 283: 20330 - 20341 | Link | ||
G3K |
Human pancreas carcinoma cell line (derivat of MIA PaCa-2) | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | L. Qin, PhD Thesis, 2014, Indiana University | |||
G3K |
Human pancreas carcinoma cell line (derivat of MIA PaCa-2) | Human | digestive organs | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | L. Qin, PhD Thesis, 2014, Indiana University | |||
G3K |
Human pancreas carcinoma cell line (derivat of MIA PaCa-2) | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | L. Qin, PhD Thesis, 2014, Indiana University | |||
GH3 |
Rat pituitary gland neoplasm cancer cell line (somatotropic) | ATCC ® ATCC CCL82.1 | Rat | brain | cell line | adherent | plasmid | Metafectene PRO | publication | G. Brigantea et al., Mol. and Cell. Endocrinology, 2019, 482: 37–44, doi.org/10.1016/j.mce.2018.12.005 | Link | ||
GL15 |
Human glioblastoma cell line | Human | brain | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | R. Xie et al., Oncology Reports, 2013, 29: 177-184, 2013, DOI: 10.3892/or.2012.2102 | Link | ||
GL15 |
Human glioblastoma cell line | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene | publication | R. Xie et al., Oncology Reports, 2013, 29: 177-184, 2013, DOI: 10.3892/or.2012.2102 | Link | ||
GMSM-K |
Human non-tumor-derived immortalized gingival epithelial cell line | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | K. Konopka et al., Cell Mol Biol Lett, Jan 2009; 14(1): 70-89 | ||||
GP2-293 |
HEK 293-based retroviral packaging cell line | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | K. Hasse, Dissertation, 2012, Freie Universität Berlin | Link | ||
GP2-293 |
Human embrionic kidney retroviral packaging cell line (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | J. Lausen et al., J. Biol. Chem., Feb 2010; 285: 5338 - 5346 | Link | ||
GP202 |
Human gastric carcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | virusproduction | Metafectene | publication | M.-H. Tsai et al., Oncotarget, 2017, 8 (6): 10238-10254 | Link | ||
Gsalpha |
Human prostate cancer cell line that overexpresses the Gs-alpha protein (derivat of PC3) | Human | genital tract | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | K. A. Iczkowski et al., Mol Biotechnol, Oct 2004; 28(2): 97-103 | |||
Gsalpha |
Human prostate cancer cell line that overexpresses the Gs-alpha protein (derivat of PC3) | Human | genital tract | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | A. L. Omara-Opyene et al., Lab Invest., 2004 Jul; 84(7):894-907 | |||
Gsalpha-QL |
Human prostate cancer cell line that overexpresses the Gs-alpha protein (derivat of PC3) | Human | genital tract | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | K. A. Iczkowski et al., Anticancer Res, Jul 2006; 26: 2863 - 2872 | Link | ||
H35 |
Rat hepatoma cell line | Rat | digestive organs | cell line | adherent | plasmid | Metafectene | publication | N. Sato et al., Int. Immunol., Dec 2005; 17: 1543 - 1552 | Link | |||
H357 |
Human oral squamous cell carcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | K. Konopka et al., Cell Mol Biol Lett, Jan 2005; 10(3): 455-70 | ||||
H357 |
Human oral squamous cell carcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | K. Konopka et al., Cell Mol Biol Lett, Jan 2009; 14(1): 70-89 | ||||
H357 |
Human oral squamous cell carcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | N. Düzgünes et al., Methods in Enzymology, 2012, 509, DOI: 10.1016/B978-0-12-391858-1.00018-6 | ||||
H376 |
Human oral squamous cell carcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | K. Konopka et al., Cell Mol Biol Lett, Jan 2009; 14(1): 70-89 |